Marketresearchnews

Wednesday, 11 August 2021

Flexible Spinal Implants Market 2020 Global Trend, Segmentation and Opportunities Forecast To 2027

Technological advancements in spine implants, increasing aging and obese population, rising cases of spine deformities, demand for minimally invasive spine surgery, growth in the number of hospitals offering spinal surgeries are fueling the growth of global flexible spinal implants market. The market restraints are stringent product approval process, uncertain reimbursement scenario, high cost of treatment procedures, concerns about safety of advanced products etc.

Considering all these factors the market for flexible spinal implants is expected to reach 4 billion USD by the end of 2023, this market is projected to growing at a CAGR of ~ 13.2 % during 2017-2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/779

Key Players of Global Flexible Spinal Implants Market:

Key players profiled in the report are Paradigm Spine LLC, Medtronic plc., Abbott Spine, Inc., Raymedica, K2M Group Holdings, Stryker Corporation, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Alphatec Holdings, Inc., NuVasive, Inc., Orthofix International N.V., and others.
Intended Audience

Global flexible spinal implants solution providers, manufacturers & suppliers
Research and development (R&D) companies
Market research and consulting service providers
Academic institutes and universities

Market Segments:

The global flexible spinal implants market is segmented on the basis of type and applications. Based on type, the market has been segmented as rods, hooks, pedicle screws, plates, cages and other. Based on the applications, the market has been segmented as thoracic, lumbar, cervical, artificial discs and other.

Study objectives:

To provide a detailed analysis of the market structure along with estimated future growth forecast for the next 6 years about various segments and sub-segments of the global flexible spinal implants market.
To provide insights about factors affecting the market growth.
To analyze the global flexible spinal implants market based on various factors – price analysis, supply chain analysis, Porters Five Force analysis etc.
To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries – Americas, Europe, Asia Pacific along with Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future growth prospects.
To provide country level analysis of the market’s segments which includes by type and applications.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape of the market.
To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new disease developments along with research and developments that are currently taking place in the global flexible spinal implants markets.

Regional Aanalysis:

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is the fastest region because of large unmet needs which is led by China and India. The Middle East and Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/flexible-spinal-implants-market-3755

Tuesday, 10 August 2021

Muscle Stimulator Market: Drivers, Restraints, Opportunities, and Threats (2020-2027)

The muscle stimulators use electric current to elicit contraction in muscles or nerves. The electric signal has intensity and frequency which mimics the nerve signal system.

The muscle stimulator market is also witnessing high technological development. The manufacturing of medical devices in general and muscle stimulators in particular is also undergoing changes. The latest technological advancements include active research in frequencies and strength of electric current used for muscle stimulation. Increasing miniaturization and portability of the muscle stimulator devices is another development that is driving the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/779

Market fragmentation and falling profit margin are significant threats to the market. The rise of low cost manufacturing economies such as China are challenging the high-tech segment. The muscle stimulators market credibility is being challenged by the rise of spurious low quality products. There has been cases of burns and skin irritation due to improper use of these low quality muscle stimulators.

The muscle stimulator market is also becoming more customer oriented and there is increasing demand for personalization and customization which has created the demand for smart muscle stimulators. The muscle stimulators today are a far cry from what they use to be. The latest hi-tech muscle stimulators use the advanced software’s which can set the device into a predefined cycle with suitable shifts. The latest muscle stimulators have started getting synchronized with mobiles. Mobile apps will eventually contain all the data in one single point. Connected healthcare muscle stimulators seems to be the future due to their cost reducing effect and the ability to converge data at a single point for analysis.

Global Muscle stimulator Market Players:

Key players profiled in the report are DJO Global, Inc., Mettler Electronics Corp., Axiobionics, Zynex, NeuroMetrix, Inc., OMRON Corporation, Tone-A-Matic.

Segmentation:

The global muscle stimulator market is segmented on the basis of products. Based on the products, the market has been segmented as transcutaneous electrical nerve stimulator, burst mode alternating current, neuromuscular electric stimulation, and interferential current. Based on the application, the market has been segmented as pain management, neurological and movement disorder management and musculoskeletal disorder management.

Browse More Details of the Report: https://www.marketresearchfuture.com/reports/muscle-stimulator-market-779

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

New research report offers detailed research on developments in Acute Myeloid Leukemia Treatment Market 2027

Acute myeloid leukemia (AML) is a cancer of the myeloid blood cells, causing extreme and rapid growth of abnormal white blood cells of the bone marrow. The rapid buildup of abnormal white blood cells causes interference in the production of normal blood cells. AML has a propensity to increase towards age. Replacement of normal bone marrow with cancer cells causes a drop in blood constituents such as red blood cells, platelets, white blood cells etc. which causes symptoms such as fatigue, breathlessness, easy bruising and bleeding, and increased risk of infection. The market driving factors for acute myeloid leukemia (AML) are rise in risk factors such as exposures to carcinogens such as ionizing radiation, chemicals etc. Presence of other blood disorders and genetics is also involved for the higher risk of AML. Other market drivers are increasing number of cancer hospitals, greater awareness, good reimbursement scenario etc. The market constraints are poor cure rates of the present drugs, serious side effects of the drugs etc.

Considering all these factors the market for acute myeloid leukemia treatment is expected to reach $ 1.2 billion by the end of 2023, this market is projected to growing at a CAGR of Approx 5.3 % during 2017-2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3223

Key players of Global Acute Myeloid Leukemia Treatment Market

Key players profiled in the report are Johnson & Johnson, Pfizer Inc., Celgene Corporation, Ambit Biosciences Corporation, Cyclacel Pharmaceuticals Inc. Novartis AG and Sanofi, Bristol Myers Squibb and others.

Segments

The global acute myeloid leukemia treatment market is segmented on the basis of disease type. Based on the disease type, the market has been segmented as myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia and megakaryocytic. Based on the treatment, the market has been segmented as chemotherapy, and hematopoietic stem cell transplantation. Chemotherapy is further sub-segmented into induction and post remission.

Intended Audience

Global acute myeloid leukemia treatment solutions providers.
Research and development (R&D) companies
Market research and consulting service providers
Academic institutes and universities

Regional Analysis

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and presence of large hospitals. Asia pacific region will be the fastest region because of large unmet needs which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions.

The report for Global Acute myeloid leukemia treatment Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Browse More Details of the Report: https://www.marketresearchfuture.com/reports/acute-myeloid-leukemia-treatment-market-3223

About Market Research Future:

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Research report covers the Lithotripsy Market Forecasts and Growth, 2020-2027

Lithotripsy is a medical procedure which involves breaking stones present in the bladder, kidney, and ureter into tiny pieces through the use of high-energy shock waves so that they can be easily passed through the urine. Lithotripsy is the most common line of treatment for kidney stones. The global lithotripsy market is anticipated to capture a moderate CAGR of 4.1 % over the forecast period. The global lithotripsy market is likely to attain USD 524.9 Mn by the end of 2023.

The growing prevalence of urological disorders is one of the main factors boosting the growth of the global lithotripsy market. Additionally, one of the main advantages associated with lithotripsy is that it does not involve any incision. Growing preference for minimally -invasive and noninvasive medical procedures is a prime factor augmenting the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4213

Increasing investment by market players on the development of novel devices and innovation has resulted in various product launches which are expected to augur market growth over the forecast period. Other factors fostering market growth include improvement in reimbursement scenario, the rise in the aging population, and spreading awareness regarding the procedure.

However, very large stones cannot be treated with lithotripsy and lithotripsy is not suitable for every patient who might impede the growth of the market over the forecast period. Moreover, lithotripsy is not suitable for pregnant women, people with bleeding disorders, morbidly obese people, and people with severe skeletal abnormalities. The underlying potential risk of causing injuries to the kidney is also a factor which restricts patients to opt for the procedure. However, advancements in technology and innovation in procedures is likely to present growth opportunities to the global lithotripsy market.

Segmentation

The global lithotripsy market has been segmented based on type and end user.

By type, the global lithotripsy market has been segmented into extracorporeal shock wave lithotripsy (ESWL), intracorporeal (endoscopic lithotripsy), percutaneous lithotripsy, and others. The intracorporeal segment has been segmented into laser lithotripsy, electrohydraulic lithotripsy, mechanical lithotripsy, and ultrasonic lithotripsy.

By end user, the global lithotripsy market has been segmented into hospitals and clinics, research laboratories, academic institutes, and others.

Regional Analysis

By region, the global lithotripsy market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

The Americas is the largest market for lithotripsy and held the largest share of the market in 2016. The widespread prevalence of urology disorders and the presence of a massive pool of diabetic patients in the region drive the Americas market. Moreover, robust healthcare sector, favorable reimbursement scenario, and high healthcare expenditure in the region can be credited for the growth of the market.

Europe commands the second position in the global lithotripsy market where Western Europe accounts for the lion's share of the market. High healthcare expenditure and spreading awareness about new products and therapies in the region can be credited for the growth of the market.

APAC is the fastest growing market for lithotripsy. Expanding healthcare sector, improving reimbursement scenario and the existence of a broad patient base in the region stimulates the growth of the market. The MEA market is expected to grow at a moderate pace over the forecast period.

Competitive Landscape

EDAP TMS (France), Boston Scientific (US), Medispec LTD (US), Dornier MedTech.(Germany), Siemens Healthcare GmbH (Germany), STORZ MEDICAL AG (Switzerland), DIREX, S.L. (Spain), Elmed Electronics & Medical Industry & Trade Inc.(Turkey), Jena Med Tech GmbH (Germany), Olympus Corporation (Japan) are the key players in the global lithotripsy market.

Browse More Details of the Report: https://www.marketresearchfuture.com/reports/lithotripsy-market-3200

About Market Research Future:

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

MEA Urinary Tract Infection (UTI) Drugs Market Growth, Trends and Value Chain 2020-2027

UTI drugs are used for the treatment of urinary tract infection caused by bacterial or fungal infections. World Health Organization (WHO) estimates that approximately 50 % of women have UTI at some point in their lives resulting in more than $1 million hospitalizations per year. WHO estimates the cost of UTI infections to be annually greater than $1 billion. It has further been stated that chances of boys being diagnosed with UTI is 1% while chances of girls being diagnosed with UTI is 3 to 8%. The Middle East and Africa UTI drugs market is growing due to factors such as catheter associated UTI, hospital borne infections (nosocomial infections), child birth, old age, obesity, growing health awareness especially about women health etc. On the other hand market constraints includes excellent efficacy of present antibiotics specially quinolones, growing drug resistance, unmet clinical needs, increasing incidence of chronic diseases etc. However, the rise of drug resistance has created the need for novel acting antibiotic. The future of UTI treatment seems to be development of biologics with greater market development especially with respect to poorly growing African market. The loss of patents, weakening developed pipelines and poor expenditure on health in African region had further constrained the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2540

The Middle East and Africa UTI drugs market has been segmented into drug class which includes quinolones, aminoglycosides, β-lactam, azoles and others. Among all these drug classes quinolones have the largest market value due to their broad variety and excellent efficacy. The share of aminoglycosides have been reduced by a small margin as this drug is resistance. Thus the current trend in UTI treatment is combined drug regimen. The market threat includes a form of substandard, counterfeit and spurious drugs have emerged. However it has to be noted that a huge unmet need exists for these drugs in the Middle East and African region.

Key Players:

Major participants of this market are: Bayer AG, Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Cipla Inc., Dr. Reddy’s Laboratories Ltd. and others.

Middle East and Africa UTI Drugs market:

The Middle East and Africa UTI drugs market has been evaluated to be growing market and is expected that the market will grow moderately in the future. The Middle East and Africa UTI drugs market is expected to grow with the CAGR of 4.35% during the forecast period. The growth will primary be led by unmet medical needs and rising incomes of the population.

Regional Analysis:

Depending on geographic region, UTI drugs market is segmented into following countries: UAE, Egypt, Saudi Arabia, Kuwait, Qatar and Oman; UAE is the largest market followed by Egypt. However the future market will be led by poorly developed parts of Africa due to large unmet needs.

Market Segmentation:

Middle East and African UTI drugs market has been segmented on the basis of drug class which comprises of quinolones, aminoglycosides, β-lactam, azoles and others. On the basis of clinical Indications the market is segmented into urethritis, cystitis and pyelonephritis. On the basis of end users, market is segmented into hospitals and self-administered.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/mea-uti-drugs-market-2540

Pharmaceutical Filtration Market – Insights on Upcoming Trends 2027

Filtration is the process that aids in separating the suspended particles from a particular medium by passing it through a membrane. It is considered as one of the most important processes adopted in the pharmaceutical sector. The process of filtration can be combined with various other operations. However, it should be noted that filtration is far different from sieving, wherein separation is carried out with the help of a single perforated layer. However, in filtration, the multi-layer lattice is typically used. This technique is used across different processes like bulk and solvent filtration, air filtration, and water filtration.

Filtration in the pharmaceutical industry is used for the purification and separation of the component and for also maintaining the sterile conditions during the process in order to prevent contamination. The different methods used for filtration depends upon the component that require to be filtered.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2432

The global market of pharmaceutical filtration devices according to Market Research Future (MRFR) is expected to reach a projected valuation of USD 23 billion by the end of the forecast period in 2022. The factors influencing the demand of the global market are the increasing growth of the pharmaceutical sector and the rapid-scale growth in the generic drug production. At the same time, strict requirements in regards to cleanliness in manufacturing facilities, rise in the manufacturing level of vaccines due to the widespread prevalence of diseases like dengue, chikungunya, and malaria, and the increasing production of varying large molecules are some of the other driving factors of the global market. Additionally, increasing research and development activities and advancement in filtration techniques are also key drivers of the market.

However, the huge requirement of capital for setting up new facilities of production and strict regulations of government for legalizing the process of filtration are anticipated to cause hindrance to the overall growth of the global market during the forecast period.

Market Segmentation

The global pharmaceutical filtrations devices market segmentation is based in terms of product, applications, and filtration types.

By types, the market includes grade filtration (liquid and gas), water filtration, air filtration, chemical filtrations, and absorptive filtrations.

By product, the market segments into media filters, membrane filters, cartridges and capsule filtration, and others.

By application, the market includes cell separation, water purification, air purification, sterilization, media and buffer filtrations, and others.

Regional Analysis

The geographical segmentation of the global pharmaceutical filtration devices market is divided into the following regions: Americas, Asia Pacific, Europe, and the Middle East & Africa.

North America holds the dominant position of the global market in terms of both value and volume. It holds the largest share of the market and is expected to grow further in the coming years.

The European region standing in the second position in the global standings of the pharmaceutical filtration devices market is expected to continue its surge upwards to catch up to the North American region. Advancements in technology, the active presence of various large and prominent market players, rising manufacturing of generic drugs and biopharmaceutical products are expected to also drive the market in this region.

The market growth in the Asia Pacific region is also expected to expand at a rapid pace. This is due to the rising government initiatives and funding, rising healthcare expenditure, increasing prevalence of diseases like malaria, rabies, and polio, and growing investments by leading market players in emerging economies like India and China.

Competitive Landscape

The global pharmaceutical filtration devices market hosts numerous key players, including Merck KGaA (Germany), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Pall Corporation (U.S.), Koch Membrane Systems Inc. (U.S.), Alfa Laval (Sweden), Parker Hannifin Corporation (U.S.), Graver Technologies, LLC (U.S.), and GEA Group (Germany).

April 26^th, 2019, Amazon Filters identified and selected Making Pharmaceuticals Exhibitions & Conference of 2019 the place to showcase the company’s latest filter housings and microfiltration filter cartridges.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/pharmaceutical-filtration-devices-market-2432

Anti-epilepsy drugs Market Insights Analysis 2020-2027

The global anti-epilepsy drugs market is expected to exhibit a solid 3.79% CAGR over the forecast period, according to the latest research report from Market Research Future (MRFR). The global anti-epilepsy drugs market was valued at USD 3.7 billion in 2015 and is expected to reach USD 4.8 billion by 2022. The report presents a comprehensive overview of the global anti-epilepsy drugs market, including a detailed analysis of the market’s major drivers and restraints, major players, and other factors and trends affecting the market’s movement. The short-term and long-term impact of the coronavirus pandemic on the anti-epilepsy drugs market is also studied in the report.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2345

Anti-epilepsy drugs are drugs formulated to counter epilepsy, a neurological disorder characterized by seizures. The rising prevalence of epilepsy and rising awareness about the disease are likely to be the major drivers for the global anti-epilepsy drugs market over the forecast period. Around 24 million people around the world suffer from epilepsy. Rising awareness about the disease is a major driver for the global anti-epilepsy drugs market. Due to its puzzling origins, epilepsy has always been shrouded in mystery. This has led to a lack of awareness about effective cures for the condition. However, this condition has reversed in the last few decades, with the development of effective treatments for the disease resulting in growing awareness around the world. This is likely to remain a major driver for the global anti-epilepsy drugs market over the forecast period.

On the other hand, the unknown origin of epilepsy is likely to remain a key restraint on the global anti-epilepsy drugs market, as this makes it difficult to develop effective cures against the disease. Despite growing research, the origins of epilepsy have remained elusive, making it difficult to develop effective cures. The loss of patents of anti-epilepsy drugs such as Neurontin and Lyrica is also likely to be a major restraint on the global anti-epilepsy drugs market over the forecast period.

Competitive Leaderboard:

Leading players in the global anti-epilepsy drugs market include Cephalon Inc., Shire Pharmaceuticals Ltd., Sanofi SA, Novartis International AG, GSK plc, Abbott Laboratories, UCB Pharma Ltd., Johnson & Johnson, and Pfizer Inc. Major players in the global anti-epilepsy drugs market are likely to engage in product development in the coming years, as the development of effective anti-epilepsy drugs has become attainable for players in the market. The development of generics is also likely to remain a major trend in the global anti-epilepsy drugs market over the forecast period.

Segmentation:

The global anti-epilepsy drugs market is segmented on the basis of type of seizure, generation, and region.

By type of seizure, the global anti-epilepsy drugs market is segmented into generalized seizures and partial-onset seizures.

By generation, the global anti-epilepsy drugs market is segmented into first-generation, second-generation, and third-generation anti-epilepsy drugs. Third-generation anti-epilepsy drugs are likely to carve out an important share in the global anti-epilepsy drugs market over the forecast period.

Regional Analysis:

The Americas and Europe dominate the global anti-epilepsy drugs market with an almost equal share. However, over the forecast period, the Americas market is likely to exhibit higher growth, with the Americas market pulling ahead of Europe by 2022. North America is the major regional market within the Americas and is likely to remain the major revenue generator over the forecast period. The U.S. is likely to remain the leading regional market over the forecast period due to the easy availability of advanced anti-epilepsy therapeutics in the region and the growing awareness about anti-epilepsy drugs in the region. The presence of leading anti-epilepsy drugs market players in the region has led to a growing presence of the market in the region, leading to the region establishing a strong share in the global anti-epilepsy drugs market. Europe is also an important regional market for anti-epilepsy drugs.

Asia Pacific is expected to grow at the highest CAGR over the forecast period.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/anti-epilepsy-drugs-market-2345